{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:25:55Z","timestamp":1790886355768,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    The coexistence of benign mesonephric-like proliferation (MLP), mesonephric-like hyperplasia (MLH), and mesonephric-like adenocarcinoma (MLA) with ovarian mucinous cystadenoma or mucinous borderline tumor (MBT) has been previously reported; however, this phenomenon is exceedingly rare, and understanding of the pathology and biology remains limited. Here we report additional cases, with an emphasis on expanded observations and novel pathologic features. This series included 9 cases: (1) 2 cases of mixed MLA and endometrioid adenocarcinoma associated with cystic mucinous neoplasm of lower gastrointestinal (GI) type (case 1) or mucinous cystadenoma (case 2); (2) 1 case of MLA associated with MBT and mucinous adenocarcinoma (case 3); (3) 4 cases of MLA associated with MBT (cases 4 and 5) or mucinous cystadenoma (cases 6 and 7); and (4) 2 cases of MLP\/MLH associated with MBT (cases 8 and 9). All mesonephric-like lesions were diffusely positive for PAX8 and either diffusely (7 cases) or focally (2 cases) positive for GATA3. Focal TTF-1 expression was observed in 4 cases (4\/9, 44.4%). All mucinous tumors, except for case 1, showed either focal (4 cases) or diffuse (4 cases) PAX8 positivity. Molecular analysis in case 1 revealed a common\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    p.G12A driver mutation in all 3 tumor components (MLA, endometrioid adenocarcinoma, and mucinous tumor), indicating clonal relatedness. In contrast, pathogenic somatic mutations in\n                    <jats:italic toggle=\"yes\">ARID1A<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">DNMT3A<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">TET2<\/jats:italic>\n                    were detected only in the MLA and endometrioid adenocarcinoma, but not in the mucinous tumor component, suggesting lineage-specific differentiation. Notably, case 1 represents the first reported example of a mesonephric-like lesion associated with a mucinous tumor exhibiting lower GI morphology and immunophenotype. Case 3 represents the first case with mucinous adenocarcinoma in this scenario. Case 9 represents the first reported instance in which both ovaries were independently involved by MLP\/MLH and MBT. The presence of benign MLP\/MLH alongside MLA suggests that the former may represent noncancerous precursor lesions with the potential to develop into MLA; they may represent benign (MLP) or borderline (MLH) mesonephric-like lesions. Whether mesonephric-like lesions serve as precursors of ovarian mucinous tumors remains debated, but their coexistence in the ovary, as documented in 20 cases to date (including previously published cases and the current series), may represent a unique biological process and provide an ideal model for investigating mechanisms of transdifferentiation and tumorigenesis.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002573","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:00:25Z","timestamp":1779868825000},"page":"1086-1096","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Ovarian Mucinous Neoplasms Associated With Mesonephric-like Lesions"],"prefix":"10.1097","volume":"50","author":[{"given":"Colton","family":"Smith","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dudley","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Savage","sequence":"additional","affiliation":[{"name":"Pathology, University of Iowa Health Care, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van de Vijver","sequence":"additional","affiliation":[{"name":"Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Hong","sequence":"additional","affiliation":[{"name":"Pathology, The Sixth Medical Center of PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Song","sequence":"additional","affiliation":[{"name":"CellNetix Pathology and Laboratories, LLC. Tukwila, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6zde","family":"Kir","sequence":"additional","affiliation":[{"name":"Pathology, Istanbul Medeniyet University, G\u00f6ztepe Prof. Dr. S\u00fcleyman Yal\u00e7in City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kearns","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaram","family":"Shakiba","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathi H.","family":"Adamson","sequence":"additional","affiliation":[{"name":"CellNetix Pathology and Laboratories, LLC. Tukwila, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saron A.","family":"Smith","sequence":"additional","affiliation":[{"name":"CellNetix Pathology and Laboratories, LLC. Tukwila, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathology, The First Medical Center of PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Pathology, The Sixth Medical Center of PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Liu","sequence":"additional","affiliation":[{"name":"Pathology, The Seventh Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0515-4194","authenticated-orcid":false,"given":"Deyin","family":"Xing","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Gynecology and Obstetrics"},{"name":"Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/his.14892","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterization of mixed tumors and mesonephric-like carcinosarcomas","volume":"82","author":"Mirkovic","year":"2023","journal-title":"Histopathology"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/his.13970","article-title":"Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions","volume":"76","author":"McCluggage","year":"2020","journal-title":"Histopathology"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PAS.0000000000001766","article-title":"Extrauterine mesonephric-like neoplasms: expanding the morphologic spectrum","volume":"46","author":"Deolet","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"100657","DOI":"10.1016\/j.gore.2020.100657","article-title":"Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: a case report and review of the literature","volume":"34","author":"Seay","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PGP.0000000000001154","article-title":"Expanded histologic lineage and origin of mesonephric-like adenocarcinoma: a clinicopathologic study of 9 cases","volume":"45","author":"Shi","year":"2026","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a Mullerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a Mullerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-020-01012-z","article-title":"Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis","volume":"15","author":"Dundr","year":"2020","journal-title":"Diagn Pathol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/PGP.0000000000000868","article-title":"Ovarian combined serous borderline tumor\/low-grade serous carcinoma and mesonephric-like lesion: report of 2 cases with new observations","volume":"42","author":"Nilforoushan","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/10668969231213390","article-title":"Mixed mesonephric-like adenocarcinoma, clear cell carcinoma, and endometrioid carcinoma arising from an endometriotic cyst","volume":"32","author":"Nagase","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/path.4572","article-title":"Clonality analysis of combined Brenner and mucinous tumors of the ovary reveals their monoclonal origin","volume":"237","author":"Wang","year":"2015","journal-title":"J Pathol"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41379-019-0401-y","article-title":"Two types of primary mucinous ovarian tumors can be distinguished based on their origin","volume":"33","author":"Simons","year":"2020","journal-title":"Mod Pathol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"155336","DOI":"10.1016\/j.prp.2024.155336","article-title":"Mucinous cystadenoma and benign mesonephric-like proliferation in the ovary - Further evidence for clonal relationship","volume":"258","author":"Hiller","year":"2024","journal-title":"Pathol Res Pract"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/PAS.0000000000001903","article-title":"Mucinous tumor coexisting with mesonephric-like proliferation\/tumor in the ovary: a Novel Association","volume":"46","author":"Nilforoushan","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/diagnostics12081901","article-title":"Mucinous borderline tumor associated with mesonephric-like proliferation: further evidence for a possible new origin of ovarian mucinous neoplasms","volume":"12","author":"Zhang","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/PGP.0000000000000935","article-title":"Ovarian RASoma with mesonephric-like adenocarcinoma and mixed Mullerian components: a case report with molecular analysis demonstrating multidirectional Mullerian differentiation","volume":"42","author":"Stolnicu","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"156110","DOI":"10.1016\/j.prp.2025.156110","article-title":"Clinical and pathological analysis of 17 cases of mesonephric-like adenocarcinoma","volume":"273","author":"Kang","year":"2025","journal-title":"Pathol Res Pract"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2019.08.003","article-title":"Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva","volume":"92","author":"Xing","year":"2019","journal-title":"Hum Pathol"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/PAS.0000000000000565","article-title":"Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection","volume":"40","author":"Xing","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/his.70058","article-title":"Ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma: Clinicopathologic features and molecular analysis highlighting recurrent genetic alterations","volume":"88","author":"Zou","year":"2026","journal-title":"Histopathology"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","article-title":"Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix","volume":"42","author":"Xing","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1158\/1078-0432.CCR-18-4278","article-title":"Lineage-specific alterations in gynecologic neoplasms with choriocarcinomatous differentiation: implications for origin and therapeutics","volume":"25","author":"Xing","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.6407","article-title":"Cellular origins of mucinous ovarian carcinoma","volume":"266","author":"Meagher","year":"2025","journal-title":"J Pathol"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e31802efb45","article-title":"Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00000478-200305000-00008","article-title":"Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei","volume":"27","author":"Ronnett","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.modpat.2022.100031","article-title":"Mesonephric adenocarcinoma and mesonephric-like adenocarcinoma of the urinary tract","volume":"36","author":"Xing","year":"2023","journal-title":"Mod Pathol"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PAP.0000000000000342","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: from morphologic observations to a well-characterized carcinoma with aggressive clinical behavior","volume":"29","author":"McCluggage","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3182299c25","article-title":"Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases","volume":"35","author":"Chu","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T","article-title":"K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases","volume":"79","author":"Cuatrecasas","year":"1997","journal-title":"Cancer"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004347-200107000-00007","article-title":"k-ras mutation may be an early event in mucinous ovarian tumorigenesis","volume":"20","author":"Garrett","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20260817","first-page":"1489","article-title":"Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy","volume":"53","author":"Mok","year":"1993","journal-title":"Cancer Res"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"155862","DOI":"10.1016\/j.prp.2025.155862","article-title":"Ovarian mucinous tumors do not usually harbor a mesonephric-like component","volume":"268","author":"Sim","year":"2025","journal-title":"Pathol Res Pract"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:00:17Z","timestamp":1786953617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002573"}},"subtitle":["An Updated Study With Novel Pathologic Features"],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002573","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2026-03-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}